Dear colleagues,
We are currently liaising with our LIMS supplier (Technidata, TDLIMS) for real-time AKI detection. Has anyone had any good experience or advice on implementation of the rules based on the KDIGO guidelines that they would be willing to share?
Additionally, with regard to AKI stage 1, I seek clarification on 1) the absolute increase stipulated in the guidance is 26.5umol/L, are labs therefore using 26 or 27? 2) When exactly is the 90 day reference interval for a baseline creatinine applicable? Is this just for AKI stages 2 and 3, or can we look at previous 90 days for AKI stage 1 (≥1.5 to 1.9x baseline) if there isn’t a creatinine result from within the previous 7 days.
Furthermore, are LIS systems able to recognise the lowest (baseline) creatinine from within the previous 3 months, assuming that the previous creatinine result was not the baseline result?
All help and guidance gratefully appreciated.
Best wishes
Phil
___________________________________
Dr Phillip J Monaghan BSc MSc PhD
Principal Clinical Scientist
Department of Clinical Biochemistry
The Christie Hospital NHS Foundation Trust
Wilmslow Road
Withington
Manchester
M20 4BX
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|